PE20010679A1 - Uso de inhibidores de secrecion de apolipoproteinas b y/o de proteina de transferencia de trigliceridos microsomales - Google Patents
Uso de inhibidores de secrecion de apolipoproteinas b y/o de proteina de transferencia de trigliceridos microsomalesInfo
- Publication number
- PE20010679A1 PE20010679A1 PE2000001184A PE0011842000A PE20010679A1 PE 20010679 A1 PE20010679 A1 PE 20010679A1 PE 2000001184 A PE2000001184 A PE 2000001184A PE 0011842000 A PE0011842000 A PE 0011842000A PE 20010679 A1 PE20010679 A1 PE 20010679A1
- Authority
- PE
- Peru
- Prior art keywords
- apolipoprotein
- microsomal
- transfer protein
- triglycerid
- cyane
- Prior art date
Links
- 101710095342 Apolipoprotein B Proteins 0.000 title abstract 2
- 102100040202 Apolipoprotein B-100 Human genes 0.000 title abstract 2
- 239000003112 inhibitor Substances 0.000 title abstract 2
- 230000003228 microsomal effect Effects 0.000 title abstract 2
- 102000004169 proteins and genes Human genes 0.000 title abstract 2
- 108090000623 proteins and genes Proteins 0.000 title abstract 2
- 230000028327 secretion Effects 0.000 title abstract 2
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 abstract 2
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical class [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 2
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 abstract 2
- DHHVAGZRUROJKS-UHFFFAOYSA-N phentermine Chemical compound CC(C)(N)CC1=CC=CC=C1 DHHVAGZRUROJKS-UHFFFAOYSA-N 0.000 abstract 2
- DBGIVFWFUFKIQN-VIFPVBQESA-N (+)-Fenfluramine Chemical compound CCN[C@@H](C)CC1=CC=CC(C(F)(F)F)=C1 DBGIVFWFUFKIQN-VIFPVBQESA-N 0.000 abstract 1
- DBGIVFWFUFKIQN-UHFFFAOYSA-N (+-)-Fenfluramine Chemical compound CCNC(C)CC1=CC=CC(C(F)(F)F)=C1 DBGIVFWFUFKIQN-UHFFFAOYSA-N 0.000 abstract 1
- -1 2-ACETYLAMINOETHYL Chemical class 0.000 abstract 1
- 150000003973 alkyl amines Chemical class 0.000 abstract 1
- 239000000883 anti-obesity agent Substances 0.000 abstract 1
- 229940125710 antiobesity agent Drugs 0.000 abstract 1
- OZVBMTJYIDMWIL-AYFBDAFISA-N bromocriptine Chemical compound C1=CC(C=2[C@H](N(C)C[C@@H](C=2)C(=O)N[C@]2(C(=O)N3[C@H](C(N4CCC[C@H]4[C@]3(O)O2)=O)CC(C)C)C(C)C)C2)=C3C2=C(Br)NC3=C1 OZVBMTJYIDMWIL-AYFBDAFISA-N 0.000 abstract 1
- 229960002802 bromocriptine Drugs 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229960004597 dexfenfluramine Drugs 0.000 abstract 1
- 229960002179 ephedrine Drugs 0.000 abstract 1
- 229960001582 fenfluramine Drugs 0.000 abstract 1
- 235000012631 food intake Nutrition 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- AHLBNYSZXLDEJQ-FWEHEUNISA-N orlistat Chemical compound CCCCCCCCCCC[C@H](OC(=O)[C@H](CC(C)C)NC=O)C[C@@H]1OC(=O)[C@H]1CCCCCC AHLBNYSZXLDEJQ-FWEHEUNISA-N 0.000 abstract 1
- 229960001243 orlistat Drugs 0.000 abstract 1
- 229960003562 phentermine Drugs 0.000 abstract 1
- KWGRBVOPPLSCSI-WCBMZHEXSA-N pseudoephedrine Chemical compound CN[C@@H](C)[C@@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WCBMZHEXSA-N 0.000 abstract 1
- 229960003908 pseudoephedrine Drugs 0.000 abstract 1
- UNAANXDKBXWMLN-UHFFFAOYSA-N sibutramine Chemical compound C=1C=C(Cl)C=CC=1C1(C(N(C)C)CC(C)C)CCC1 UNAANXDKBXWMLN-UHFFFAOYSA-N 0.000 abstract 1
- 229960004425 sibutramine Drugs 0.000 abstract 1
- 150000003626 triacylglycerols Chemical class 0.000 abstract 1
- 229920002554 vinyl polymer Polymers 0.000 abstract 1
- ORGHESHFQPYLAO-UHFFFAOYSA-N vinyl radical Chemical class C=[CH] ORGHESHFQPYLAO-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16451399P | 1999-11-10 | 1999-11-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20010679A1 true PE20010679A1 (es) | 2001-06-30 |
Family
ID=22594839
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2000001184A PE20010679A1 (es) | 1999-11-10 | 2000-11-07 | Uso de inhibidores de secrecion de apolipoproteinas b y/o de proteina de transferencia de trigliceridos microsomales |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP1099438A3 (enExample) |
| JP (1) | JP2001181209A (enExample) |
| KR (1) | KR100439384B1 (enExample) |
| AU (1) | AU777542B2 (enExample) |
| CA (1) | CA2325282C (enExample) |
| CO (1) | CO5271688A1 (enExample) |
| HU (1) | HUP0004454A3 (enExample) |
| IL (1) | IL139449A0 (enExample) |
| NZ (1) | NZ508061A (enExample) |
| PE (1) | PE20010679A1 (enExample) |
| ZA (1) | ZA200006417B (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6825209B2 (en) | 2002-04-15 | 2004-11-30 | Research Triangle Institute | Compounds having unique CB1 receptor binding selectivity and methods for their production and use |
| BRPI0507462A (pt) | 2004-02-04 | 2007-07-10 | Pfizer Prod Inc | compostos de quinolina substituìdos |
| EP1890767A2 (en) * | 2005-05-27 | 2008-02-27 | Pfizer Products Inc. | Combination of a cannabinoid-1- receptor-antagonist and a microsomal triglyceride transfer protein inhibitor for treating obesity or mainataining weight loss |
| WO2008090198A1 (en) * | 2007-01-25 | 2008-07-31 | Janssen Pharmaceutica Nv | Use of mtp inhibitors for increasing levels of satiety hormones |
| JP6671363B2 (ja) | 2014-07-15 | 2020-03-25 | イッサム リサーチ ディヴェロップメント カンパニー オブ ザ ヘブリュー ユニバーシティー オブ エルサレム リミティッド | Ｃｄ４４の単離されたポリペプチドおよびその使用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1992018132A1 (en) * | 1991-04-17 | 1992-10-29 | Merck & Co., Inc. | Pharmaceutical combination for the treatment of benign prostatic hyperplasia comtaining a 5 alpha-reductase inhibitor |
| US5474993A (en) * | 1994-06-14 | 1995-12-12 | Sterling Winthrop, Inc. | Lactam inhibitors of cholesterol esterase |
| WO1996040640A1 (en) * | 1995-06-07 | 1996-12-19 | Pfizer Inc. | BIPHENYL-2-CARBOXYLIC ACID-TETRAHYDRO-ISOQUINOLIN-6-YL AMIDE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS INHIBITORS OF MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN AND/OR APOLIPOPROTEIN B (Apo B) SECRETION |
| IL126202A0 (en) * | 1996-04-30 | 1999-05-09 | Pfizer | Processes and intermediates for preparing 4'-trifluoromethylbiphenyl-2-carboxylic acid [2-(2H-[1,2,4]triazol-3-ylmethyl)-1,2,3,4-tetrahydro-isoquinolin-6-yl]-amide |
| US5883109A (en) * | 1996-07-24 | 1999-03-16 | Bristol-Myers Squibb Company | Method for lowering serum lipid levels employing an MTP inhibitor in combination with another cholesterol lowering drug |
| AU716151B2 (en) * | 1996-11-27 | 2000-02-17 | Pfizer Inc. | Apo B-secretion/MTP inhibitory amides |
| US5968950A (en) * | 1997-06-23 | 1999-10-19 | Pfizer Inc | Apo B-secretion/MTP inhibitor hydrochloride salt |
| IL133201A0 (en) * | 1998-12-04 | 2001-03-19 | Pfizer Prod Inc | Lowering blood levels of lipoproten (a) |
-
2000
- 2000-11-02 IL IL13944900A patent/IL139449A0/xx unknown
- 2000-11-02 CO CO00083607A patent/CO5271688A1/es not_active Application Discontinuation
- 2000-11-03 EP EP00309705A patent/EP1099438A3/en not_active Withdrawn
- 2000-11-07 PE PE2000001184A patent/PE20010679A1/es not_active Application Discontinuation
- 2000-11-08 CA CA002325282A patent/CA2325282C/en not_active Expired - Fee Related
- 2000-11-08 KR KR10-2000-0066044A patent/KR100439384B1/ko not_active Expired - Fee Related
- 2000-11-08 ZA ZA200006417A patent/ZA200006417B/xx unknown
- 2000-11-09 AU AU71519/00A patent/AU777542B2/en not_active Ceased
- 2000-11-09 NZ NZ508061A patent/NZ508061A/en unknown
- 2000-11-09 HU HU0004454A patent/HUP0004454A3/hu unknown
- 2000-11-10 JP JP2000344128A patent/JP2001181209A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| NZ508061A (en) | 2002-04-26 |
| ZA200006417B (en) | 2002-05-08 |
| AU777542B2 (en) | 2004-10-21 |
| AU7151900A (en) | 2001-05-17 |
| CA2325282A1 (en) | 2001-05-10 |
| IL139449A0 (en) | 2001-11-25 |
| HU0004454D0 (enExample) | 2001-01-29 |
| HUP0004454A3 (en) | 2004-04-28 |
| EP1099438A3 (en) | 2003-03-19 |
| CO5271688A1 (es) | 2003-04-30 |
| KR100439384B1 (ko) | 2004-07-09 |
| EP1099438A2 (en) | 2001-05-16 |
| KR20010051509A (ko) | 2001-06-25 |
| JP2001181209A (ja) | 2001-07-03 |
| HUP0004454A2 (hu) | 2001-10-28 |
| CA2325282C (en) | 2005-12-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20071432A1 (es) | Derivados de dihidrobenzofurano como agonistas o agonistas parciales de receptores metaloninergicos | |
| EA200300527A1 (ru) | Новые способы лечения синдрома "усталых ног" | |
| ATE302622T1 (de) | Stabilisierung von implantierbarem bioprothesegewebe | |
| EA200201214A1 (ru) | Замещенные тиоацетамиды | |
| EA200500528A1 (ru) | Пиперазинил- и диазапанилбензамиды и бензтиоамиды | |
| PE20050142A1 (es) | 2-hidroxi-3-diaminoalcanos de benzamida | |
| EA200300171A1 (ru) | Циклопентаноиндолы, композиции, содержащие данные соединения, и способы лечения | |
| EA200400648A1 (ru) | N, n'-замещенные производные 1,3-диамино-2-гидроксипропана | |
| PE20020858A1 (es) | Indanil aminas aciladas | |
| ATE304523T1 (de) | Trisubstituierte-n-((1s)-1,2,3,4-tetrahydro-1- naphthalenyl) benzamide welche p2x3 und p2x2/3 enthaltende rezeptoren inhibieren | |
| EA200200208A1 (ru) | Синергитическая композиция | |
| PE20060479A1 (es) | Compuestos heteroaril-aril-ureas como inhibidores de la quinasa | |
| EA200100780A1 (ru) | Антагонисты tweak и рецептора tweak и их использование для лечения иммунологических заболеваний | |
| PT1548032E (pt) | Péptidos kdr e vacinas que os contêm | |
| EA200400586A1 (ru) | Замещённые тиоацетамиды | |
| ES2190803T3 (es) | Iminas ciclicas como pesticidas. | |
| ECSP093601A (es) | Proteínas derivadas del virus del síndrome de mancha blanca y sus usos | |
| EA200300929A1 (ru) | Новые лекарственные композиции на основе антихолинергических средств и ингибиторов pde-iv | |
| ES2421948T3 (es) | Compuestos y composiciones para suministrar agentes activos | |
| DK1383874T3 (da) | Varianter af lipogygenase og deres anvendelse | |
| NO995963D0 (no) | Karboksamider anvendelige som 5-HTIF-agonister | |
| PE20010679A1 (es) | Uso de inhibidores de secrecion de apolipoproteinas b y/o de proteina de transferencia de trigliceridos microsomales | |
| DE60129829D1 (de) | Zyklisierte benzamid-neurokinin-antagonisten zur verwendung in therapie | |
| ATE470444T1 (de) | Alpha,beta-ungesättigte sulfone zur behandlung von zellenwucherungsstörungen | |
| IN2003CH01314A (en) | Method for production of D-pantothenic acid and/or salts thereof as adjunct for animal feedstuffs |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |